The next board meeting for Theravance Biopharma Inc is on 19 May 2026 for the purpose of Theravance Biopharma Inc Annual General Meeting for 2026See details
Theravance Biopharma Inc has a share price target of US$ 17, revenue growth forecast of -21.2%, and profit growth estimate of 0.9% for FY26, based on top 6 analyst calls.